Searched for
NAPROXEN SODIUM
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...
- The five most dangerous things you’re doing to your kidneys without even realizing, top cardiologist warnsYour kidneys are vital organs, and several everyday habits can dangerously impair their function. Good diet and hydration are crucial to ma...
- Sound businesses are the best antidote for volatility: 6 large- and mid-cap stocks with an upside potential of up to 30%The market hates uncertainty. Post the big reforms (GST and banking), the markets should have ideally been in upbeat mode this festive seas...
- Pharma stocks: With headwinds of uncertainty over, will they outperform? 7 stocks with an upside potential of up to 43%When it is Trump, logic usually flies out of the window. There is, indeed, little that is logical about the reciprocal tariffs he has annou...
- Look for good quality businesses at relatively lower valuations: 5 large-caps from different sectors with upside potential of up to 44%Our headline says “relatively” lower valuations. Now, “relatively” is used in two contexts. A stock that was trading at a PE of 93 is today...
- Stocks in the news: RIL, Wipro, JSW Steel, Tata Power and Max HealthcareThe government hiked the windfall profit tax on the export of diesel to Rs 7 per litre and brought back a tax on jet fuel exports, but slas...
- Drug makers Glenmark, Aurobindo recall products in USGlenmark Pharmaceuticals Inc, USA is recalling Fulvestrant injection, Naproxen Sodium Tablets, Chlorzoxazone tablets and Arformoterol Tartr...
- Drug makers Granules India, Jubilant Cadista recall products in US marketSalisbury-based Jubilant Cadista Pharmaceuticals Inc is a fully-owned subsidiary of Cadista Holdings Inc, which is a part of Noida-based Ju...
- Stocks in the news: SBI, Airtel, DRL, Tata Consumer and Adani Group stocksSBI, Titan, Adani Green, Godrej Consumer, Adani Gas, ICICI Lombard GIC, Bosch, Tata Communications, Hindustan Petroleum, OFSS and Apollo Ty...
- Health Ministry releases revised guidelines for home isolation of mild COVID-19 casesElderly patients aged more than 60 years and those with co-morbid conditions such as hypertension, diabetes, heart disease, chronic lung or...
- Granules India gets USFDA nod for sleep aid drugThe US Food and Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) for Naproxen Sodium and Diphenhydramin...
- Divi's Labs climbs 3% on minimal impact of USFDA alert on Visakhapatnam unitThe company has initiated necessary measures to address the concerns raised by the US-FDA and is making all efforts to fully meet the compl...
- Divi’s Laboratories nosedives 20%, hits 52-week low on USFDA’s import alertIn a filing to BSE, the drug marker said that the USFDA has exempted the company from making ten drugs.
- Aurobindo Pharma shares end with 3% gains on USFDA nodShares of Aurobindo Pharma ended with 3 per cent gains today after the company got final approval from the USFDA to manufacture and market ...
- Aurobindo Pharma climbs after USFDA nod for OTC drugThe stock soared 2.31 per cent to Rs 738 on BSE. On NSE too, shares of the company climbed 2.31 per cent to Rs 737.95.
- Twelve stocks in focus in Monday morning tradeThe Indian market is expected to open flat. Here is a list of top twelve stocks that are likely to be in focus today.
- Aurobindo Pharma gets USFDA nod for osteoporosis drug"The approved product has an estimated market size of USD 96 million for the twelve months ended January 2016 according to IMS," it said.
- DRL to rope in US cos for OTC drugsDr Reddy’s Laboratories is on course to scale up its private label drug business in the US, riding on the initial success of its tie-up wit...
- Glenmark gets USFDA approval for anti-cholesterol drugGlenmark Pharmaceuticals Ltd has received US FDA (United States Food and Drug Administration) approval for an anti-cholesterol drug Pravast...
Load More
